Drug Testing Locations in Michigan

Accredited Drug Testing has 470 drug testing centers in 901 MI cities.

Please select a city from the list below to find drug test centers in Michigan.

Why Michigan Employers Trust Our Drug Testing Services

In Michigan, maintaining a drug-free workplace is paramount. Our 469 test centers in 901 cities offer employers easy access to indispensable testing services. By partnering with us, businesses ensure safety and compliance with stringent state regulations.

Our tests are fast and precise, minimizing downtime for your staff while maintaining productivity. Access to our extensive network allows for seamless integration of drug testing into your hiring and employee maintenance protocols, safeguarding workforce quality.

The importance of our services transcends basic legality, providing a pillar of prevention and security for both the employees and the employers, covering varied industries with tailored solutions that fit specific needs.

As a Michigan employer, you can leverage our state-of-the-art testing to reinforce your commitment to a drug-free workplace, ultimately boosting your business’s reputation and operational safety.

Michigan Drug Free Workplace Programs

Michigan actively promotes a healthy and safe working environment through a range of initiatives aimed at reducing substance abuse. Employers across the state are encouraged to implement policies that deter drug use, fostering a culture focused on employee well-being and safety. While Michigan does not have a formal state-mandated Drug Free Workplace Program, many businesses adopt voluntary measures to cultivate drug-free environments, supported by resources and guidelines to facilitate program development.

Employee education and assistance play crucial roles in this effort. Michigan companies often provide access to educational materials and employee assistance programs (EAPs) to help workers address substance-related issues. By prioritizing education and support, Michigan workplaces contribute positively to their communities, reinforcing the value of a healthy workforce and underscoring the importance of maintaining drug-free standards throughout the state.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Mobile/On-Site Drug Testing

If you're an employer needing to test 25 or more employees and looking to save time and money, we offer mobile on-site drug testing where we come to you. Call us today for more information.

Michigan Laws on Drugs

Michigan has a comprehensive framework regulating the use and distribution of controlled substances. Schedule-based control deeply influences the severity of penalties, with Schedule I and II drugs attracting more severe consequences. Understanding these nuances is crucial for compliance and legal foresight.

Proponents of drug policy reform advocate for more support and treatment-focused measures. Despite shifts in public consciousness, non-marijuana drug regulations remain heavily enforced, necessitating informed adherence from individuals and employers to navigate this stringent landscape effectively.

Michigan Laws on Marijuana

Michigan law allows for the recreational use of marijuana for individuals over 21, following the 2018 legalization. Personal possession is capped at 2.5 ounces on-person and up to 10 ounces at home, necessitating secure storage for non-visible possession exceeding this amount at home.

Regulated sales occur through licensed dispensaries, with home cultivation permissible within limits—a maximum of 12 plants per residence. Despite legality, diverse implications in employment and business operations remain, warranting clear company policies regarding workplace use.

Michigan Drug Resources

Michigan Department of Licensing and Regulatory Affairs
Provides regulatory guidance and resources for drug compliance in Michigan.

MI Safer Workplaces
Offers guidelines to employers for maintaining safe, drug-free workplaces.

Healthy Michigan Plan
A healthcare plan offering resources for substance abuse treatment.

Michigan Opioids Task Force
State-driven initiative offering resources for opioid crisis management.

Michigan Department of Health & Human Services
Provides comprehensive health guidelines and substance abuse support.

Workit Health Michigan
Digital rehab support providing addiction recovery resources.

Michigan Works!
Statewide network assisting with employment resources and training.

Oakland County Health Division Addiction Services
Local resource hub for managing and treating substance use disorders.

Drug Testing Near , MI

Frequently Asked Questions

Customer Reviews